Fortis Healthcare Grants Over 1.32 Crore Stock Options Under ESOP 2026
Fortis Healthcare granted 1,32,05,200 stock options under ESOP 2026 on April 23, 2026. Each option is exercisable into one equity share of ₹10 face value. The exercise price is ₹923.10. Vesting occurs within 3 years, and exercise within 4 years of vesting.
The grant of employee stock options is a standard HR and compensation practice and typically has a limited immediate impact on the company's financial performance or stock price, unless the quantum is exceptionally large or tied to specific performance metrics.
The announcement is a routine grant of employee stock options, which is a standard practice for companies. It does not contain any immediately positive or negative financial or operational news.
Fortis Healthcare Limited has announced the grant of up to 1,32,05,200 (One Crore Thirty Two Lakhs Five Thousand Two Hundred) employee stock options under the "Fortis Healthcare Limited Employee Stock Option Scheme 2026." This decision was approved by the Nomination & Remuneration Committee during its meeting held on April 23, 2026. The meeting commenced at 12:30 PM and concluded at 01:55 PM.
Each option granted will entitle the holder to one fully paid-up equity share of face value ₹10/- upon exercise, subject to SEBI Regulations. The scheme is in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The exercise price per option is ₹923.10, determined as the closing price on the recognized stock exchange with higher trading volume as of April 22, 2026. Options will vest within a maximum period of 3 years from the grant date, and vested options can be exercised within a maximum of 4 years from the respective vesting date. The company has also hosted the intimation and a copy of the ESOP scheme on its website.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.